All In Biotech

Drug Trial Radar · NCT07805252

Trial to Study the Safety, Pharmacokinetics and Preliminary Antitumour Activity of ODM-216 in Patients With Cancer

A Phase 1/2, Open-Label, First-in-Human Trial Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumour Activity of ODM-216 in Participants With Advanced Solid Tumours

Last checked: Nov 19, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

195

Planned (sponsor's estimate)

Start

Sep 3, 2026

Primary completion

Jan 10, 2028

Study completion Jan 10, 2028

Sponsor

Sponsor type
Industry
First posted
Sep 4, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 1/2, Open-Label, First-in-Human Trial Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumour Activity of ODM-216 in Participants With Advanced Solid Tumours

Conditions

  • Advanced Solid Tumors Cancer

Interventions

  • ODM-216Drug

    ODM-216

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of dose-limiting toxicities (DLTs), treatment-emergent adverse events (TEAEs), treatment-related adverse events, and clinical laboratory abnormalities (including electrocardiogram [ECG]).Time frame: 12 months
  2. Incidence of dose-limiting toxicities (DLTs), treatment-emergent adverse events (TEAEs), treatment-related adverse events, and clinical laboratory abnormalities (including electrocardiogram [ECG]).Time frame: 22 months

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • START Barcelona - HM Nou Delfos

    Barcelona, Spain · Recruiting

  • Clinica Universidad de Navarra - Madrid

    Madrid, Spain · Recruiting

  • Hospital Universitario Fundacion Jimenez Diaz - START MADRID

    Madrid, Spain · Recruiting

  • START Madrid - CIOCC FM Sanchinarro

    Madrid, Spain · Recruiting

  • Clínica Universidad de Navarra. Pamplona

    Pamplona, Spain · Recruiting

  • START Rioja - Hospital Universitario San Pedro

    Logroño, La Rioja, Spain · Recruiting

  • NEXT Oncology - Hospital Quironsalud Madrid

    Madrid, Pozuelo de Alarcón - Madrid, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.